{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T05:34:28Z","timestamp":1740116068290,"version":"3.37.3"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003052","name":"Korea Ministry of Trade Industry and Energy","doi-asserted-by":"publisher","award":["20003883"],"award-info":[{"award-number":["20003883"]}],"id":[{"id":"10.13039\/501100003052","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","jocn-journal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jocn.2025.111039","type":"journal-article","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T03:45:16Z","timestamp":1736307916000},"page":"111039","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A common data model for oral anticoagulants-related risk of spontaneous intracranial hemorrhage"],"prefix":"10.1016","volume":"133","author":[{"given":"Noah","family":"Hong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeh-Hee","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong Hyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Jin","family":"Ha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kang Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun-Seung","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong Eun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwangsoo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Won-Sang","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jocn.2025.111039_b0005","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1161\/STR.0000000000000069","article-title":"Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the american heart association\/american stroke association","volume":"46","author":"Hemphill","year":"2015","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.jocn.2025.111039_b0010","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1474-4422(09)70340-0","article-title":"Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis","volume":"9","author":"van Asch","year":"2010","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.jocn.2025.111039_b0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.5853\/jos.2016.00864","article-title":"Epidemiology, risk factors, and clinical features of intracerebral hemorrhage: an update","volume":"19","author":"An","year":"2017","journal-title":"J Stroke"},{"issue":"10","key":"10.1016\/j.jocn.2025.111039_b0020","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1161\/STROKEAHA.107.487090","article-title":"Risk factors for intracerebral hemorrhage in a pooled prospective study","volume":"38","author":"Sturgeon","year":"2007","journal-title":"Stroke"},{"issue":"8","key":"10.1016\/j.jocn.2025.111039_b0025","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1161\/01.STR.0000080678.09344.8D","article-title":"Risk factors for intracerebral hemorrhage in the general population: a systematic review","volume":"34","author":"Ariesen","year":"2003","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.jocn.2025.111039_b0030","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1055\/s-0036-1581991","article-title":"Critical care management of intracerebral hemorrhage","volume":"36","author":"Morawo","year":"2016","journal-title":"Semin Neurol"},{"issue":"4","key":"10.1016\/j.jocn.2025.111039_b0035","first-page":"338","article-title":"Spontaneous primary intraventricular hemorrhage in adults: clinical data, etiology and outcome","volume":"19","author":"Giray","year":"2009","journal-title":"Turk Neurosurg"},{"issue":"19","key":"10.1016\/j.jocn.2025.111039_b0040","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJM200105103441907","article-title":"Spontaneous intracerebral hemorrhage","volume":"344","author":"Qureshi","year":"2001","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.jocn.2025.111039_b0045","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1161\/01.STR.26.9.1558","article-title":"Risk factors for spontaneous intracerebral hemorrhage","volume":"26","author":"Juvela","year":"1995","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.jocn.2025.111039_b0050","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1159\/000094831","article-title":"Recommendations for the management of intracranial haemorrhage - part I: spontaneous intracerebral haemorrhage. The European Stroke Initiative Writing Committee and the Writing Committee for the EUSI Executive Committee","volume":"22","author":"Steiner","year":"2006","journal-title":"Cerebrovasc Dis"},{"issue":"2","key":"10.1016\/j.jocn.2025.111039_b0055","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1212\/01.wnl.0000250340.05202.8b","article-title":"The increasing incidence of anticoagulant-associated intracerebral hemorrhage","volume":"68","author":"Flaherty","year":"2007","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jocn.2025.111039_b0060","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/s00415-014-7462-0","article-title":"Intracranial hemorrhage risk with the new oral anticoagulants: a systematic review and meta-analysis","volume":"262","author":"Caldeira","year":"2015","journal-title":"J Neurol"},{"issue":"Suppl A","key":"10.1016\/j.jocn.2025.111039_b0065","doi-asserted-by":"crossref","first-page":"A19","DOI":"10.1093\/eurheartj\/suab151","article-title":"Non-vitamin K antagonist oral anticoagulants in patients with valvular heart disease","volume":"24","author":"Fanaroff","year":"2022","journal-title":"Eur Heart J Suppl"},{"issue":"9921","key":"10.1016\/j.jocn.2025.111039_b0070","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jocn.2025.111039_b0075","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.ijcard.2015.11.097","article-title":"Intracranial hemorrhage with target specific oral anticoagulants in patients with atrial fibrillation: an updated meta-analysis of randomized controlled trials","volume":"203","author":"Kundu","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jocn.2025.111039_b0080","doi-asserted-by":"crossref","unstructured":"Hong KS, Bang OY, Kang DW, et al. Stroke statistics in Korea: part I. Epidemiology and risk factors: a report from the korean stroke society and clinical research center for stroke. J Stroke. Jan 2013;15(1):2-20. doi:10.5853\/jos.2013.15.1.2.","DOI":"10.5853\/jos.2013.15.1.2"},{"issue":"11","key":"10.1016\/j.jocn.2025.111039_b0085","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1161\/STROKEAHA.117.018773","article-title":"Effectiveness and safety of non-vitamin k antagonist oral anticoagulants in asian patients with atrial fibrillation","volume":"48","author":"Cha","year":"2017","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.jocn.2025.111039_b0090","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1161\/STROKEAHA.119.028030","article-title":"Oral anticoagulation in asian patients with atrial fibrillation and a history of intracranial hemorrhage","volume":"51","author":"Lee","year":"2020","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.jocn.2025.111039_b0095","doi-asserted-by":"crossref","first-page":"67","DOI":"10.12793\/tcp.2020.28.e11","article-title":"Common data model-based real-world data for practical clinical practice guidelines: clinical pharmacology perspectives","volume":"28","author":"Jeon","year":"2020","journal-title":"Transl Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.jocn.2025.111039_b0100","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s40273-020-00981-9","article-title":"Common problems, common data model solutions: evidence generation for health technology assessment","volume":"39","author":"Kent","year":"2021","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jocn.2025.111039_b0105","first-page":"574","article-title":"Observational health data sciences and informatics (OHDSI): opportunities for observational researchers","volume":"216","author":"Hripcsak","year":"2015","journal-title":"Stud Health Technol Inform"},{"key":"10.1016\/j.jocn.2025.111039_b0110","doi-asserted-by":"crossref","unstructured":"Ezekowitz MD, Connolly S, Parekh A, et al. Rationale and design of RE-LY: randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatran. Am Heart J. May 2009;157(5):805-10, 810.e1-2. doi:10.1016\/j.ahj.2009.02.005.","DOI":"10.1016\/j.ahj.2009.02.005"},{"issue":"12","key":"10.1016\/j.jocn.2025.111039_b0115","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocn.2025.111039_b0120","doi-asserted-by":"crossref","unstructured":"Rivaroxaban-once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: rationale and design of the ROCKET AF study. Am Heart J. Mar 2010;159(3):340-347.e1. doi:10.1016\/j.ahj.2009.11.025.","DOI":"10.1016\/j.ahj.2009.11.025"},{"issue":"10","key":"10.1016\/j.jocn.2025.111039_b0125","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jocn.2025.111039_b0130","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ahj.2009.07.035","article-title":"Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale","volume":"159","author":"Lopes","year":"2010","journal-title":"Am Heart J"},{"issue":"11","key":"10.1016\/j.jocn.2025.111039_b0135","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jocn.2025.111039_b0140","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.ahj.2010.06.042","volume":"160","author":"Ruff","year":"2010","journal-title":"Am Heart J"},{"issue":"22","key":"10.1016\/j.jocn.2025.111039_b0145","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.jocn.2025.111039_b0150","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.2146\/ajhp130243","article-title":"Management of bleeding and reversal strategies for oral anticoagulants: clinical practice considerations","volume":"70","author":"Nutescu","year":"2013","journal-title":"Am J Health Syst Pharm"},{"issue":"6","key":"10.1016\/j.jocn.2025.111039_b0155","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.thromres.2013.10.024","article-title":"Effect of warfarin on intracranial hemorrhage incidence and fatal outcomes","volume":"132","author":"Witt","year":"2013","journal-title":"Thromb Res"},{"issue":"8","key":"10.1016\/j.jocn.2025.111039_b0160","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1007\/s00415-013-6939-6","article-title":"Intracerebral hemorrhage during anticoagulation with vitamin K antagonists: a consecutive observational study","volume":"260","author":"Horstmann","year":"2013","journal-title":"J Neurol"},{"key":"10.1016\/j.jocn.2025.111039_b0165","doi-asserted-by":"crossref","unstructured":"Zemrak WR, Smith KE, Rolfe SS, et al. Low-dose Prothrombin Complex Concentrate for Warfarin-Associated Intracranial Hemorrhage with INR Less Than 2.0. Neurocrit Care. Dec 2017;27(3):334-340. doi:10.1007\/s12028-017-0422-7.","DOI":"10.1007\/s12028-017-0422-7"},{"issue":"1","key":"10.1016\/j.jocn.2025.111039_b0170","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1161\/STROKEAHA.116.014963","article-title":"Coagulation testing in acute ischemic stroke patients taking non-vitamin k antagonist oral anticoagulants","volume":"48","author":"Purrucker","year":"2017","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.jocn.2025.111039_b0175","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s12028-017-0403-x","article-title":"Coagulation testing in intracerebral hemorrhage related to non-vitamin K antagonist oral anticoagulants","volume":"27","author":"Purrucker","year":"2017","journal-title":"Neurocrit Care"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586825000116?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586825000116?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T21:27:43Z","timestamp":1740086863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586825000116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":35,"alternative-id":["S0967586825000116"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2025.111039","relation":{},"ISSN":["0967-5868"],"issn-type":[{"type":"print","value":"0967-5868"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A common data model for oral anticoagulants-related risk of spontaneous intracranial hemorrhage","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2025.111039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111039"}}